START A PH1 STUDY7 Apr 2021 10:46
From Bloomburg
“mRNA vaccines for Covid-19 have efficacy rates above 90%, much higher than the 60% rate for flu shots in a good year. But vaccine makers Moderna Inc. and Pfizer Inc., along with its partner BioNTech SE, aren’t taking any chances. Just in case, they’re already starting trials of booster shots aimed at B.1.351, the antibody-evading strain first spotted in South Africa.”
Can we start a PH1 study now, time is of the essence